Clinical Trials
Abivax gets approval to conduct Covid-19 trial in France
Biotechnology company Abivax has secured approval from France’s National Agency for the Safety of Medicines (ANSM) and French Ethics Committee (CPP) to conduct a Phase IIb/III clinical trial of ABX464 in Covid-19 patients.
The miR-AGE trial will assess the drug...
IT & Data Management
Indica Labs and Octo launch COVID digital pathology repository to support the fight against COVID-19
Indica Labs, a leading provider of computational pathology software, and Octo, a premiere information technology systems provider to the U.S. Federal Government, are pleased to announce the online COVID Digital Pathology Repository (COVID-DPR), a virtual collection of high resolution...
Press Releases
Roche’s Tecentriq receives US FDA approval for first-line monotherapy for certain people with metastatic NSCLC
Roche announced that the US FDA has approved Tecentriq® (atezolizumab) as a first-line (initial) treatment for adults with metastatic non-small cell lung cancer (NSCLC) whose tumours have high PD-L1 expression (PD-L1 stained ≥ 50% of tumour cells or...
Press Releases
Covis Pharma begins phase 3 study of asthma drug, Alvesco to treat COVID-19
Covis Pharma announced the initiation of a phase 3 clinical study to assess the safety and efficacy of its asthma drug Alvesco (ciclesonide) in non-hospitalized patients 12 years of age and older with symptomatic COVID-19. Patient recruitment for the...
Packaging & Labelling
UPS Healthcare Provides Urgent Support For Dr. Reddys Laboratories Temperature-Sensitive Medicines
UPS announced a collaboration with Dr. Reddy’s Laboratories to get 30 tons of pharmaceuticals from India to the United States via Europe. The sensitive cargo had to be shipped within a controlled temperature range to ensure product stability. Given...
Press Releases
Leinco Announces Development of Immunodiagnostic Test for COVID-19
Leinco Technologies announced an agreement with Vanderbilt University Medical Center (VUMC) to scale up production of its most promising antibodies for development of a rapid, point of care COVID-19 diagnostic test.
Under the agreement, Leinco Technologies will co-develop a rapid,...
Press Releases
Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart
Kindred Biosciences, Inc., a biopharmaceutical company developing novel biologics, announced it has entered into an agreement with Vaxart, Inc. for the manufacture of Vaxart's oral vaccine candidate for COVID-19.
"We are proud to be contributing toward the effort to develop...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read